drugset / Trial / NCT00000510
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
RandomizedDouble-blindPrevention
Summary
To determine the effectiveness of dipyridamole and aspirin in prevention of restenosis of the dilated lesion in patients who had undergone percutaneous transluminal coronary angioplasty (PTCA). Secondary aims were to determine the effectiveness of platelet inhibitor therapy in reducing the incidence of coronary events and the severity and incidence of angina.
Timeline
- Start
- 1983-09
- Primary completion
- —
- Completion
- 1988-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | — |
| Subject | Dipyridamole | Other / unclassified | — | — |